These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 27771961)
1. Building a better understanding of the burden of disease in familial chylomicronemia syndrome. Ahmad Z; Halter R; Stevenson M Expert Rev Clin Pharmacol; 2017 Jan; 10(1):1-3. PubMed ID: 27771961 [No Abstract] [Full Text] [Related]
2. The burden of familial chylomicronemia syndrome: interim results from the IN-FOCUS study. Davidson M; Stevenson M; Hsieh A; Ahmad Z; Crowson C; Witztum JL Expert Rev Cardiovasc Ther; 2017 May; 15(5):415-423. PubMed ID: 28338353 [TBL] [Abstract][Full Text] [Related]
3. The burden of familial chylomicronemia syndrome: Results from the global IN-FOCUS study. Davidson M; Stevenson M; Hsieh A; Ahmad Z; Roeters van Lennep J; Crowson C; Witztum JL J Clin Lipidol; 2018; 12(4):898-907.e2. PubMed ID: 29784572 [TBL] [Abstract][Full Text] [Related]
4. Familial chylomicronemia in a nine months old infant. Lone SW; Imdad A; Billoo AG J Coll Physicians Surg Pak; 2008 Oct; 18(10):655-6. PubMed ID: 18940129 [TBL] [Abstract][Full Text] [Related]
5. Familial Chylomicronemia Syndrome: A Clinical Guide For Endocrinologists. Falko JM Endocr Pract; 2018 Aug; 24(8):756-763. PubMed ID: 30183397 [TBL] [Abstract][Full Text] [Related]
10. Challenges in familial chylomicronemia syndrome diagnosis and management across Latin American countries: An expert panel discussion. Santos RD; Lorenzatti A; Corral P; Nogueira JP; Cafferata AM; Aimone D; Lourenço CM; Izar MC; Lima JG; Lottenberg AM; Alonso R; Garay K; Morales AR; Vargas-Uricoechea H; Peña CAC; Roman-González A J Clin Lipidol; 2021; 15(5):620-624. PubMed ID: 34920815 [TBL] [Abstract][Full Text] [Related]
11. The Chylomicronemia Syndrome Is Most Often Multifactorial: A Narrative Review of Causes and Treatment. Chait A; Eckel RH Ann Intern Med; 2019 May; 170(9):626-634. PubMed ID: 31035285 [TBL] [Abstract][Full Text] [Related]
12. Disappearance of recurrent pancreatitis after splenectomy in familial chylomicronemia syndrome. Marco-Benedí V; Lamiquiz-Moneo I; Álvarez-Sala LA; Civeira F Atherosclerosis; 2018 Aug; 275():342-345. PubMed ID: 30015297 [TBL] [Abstract][Full Text] [Related]
13. Management of a pregnant patient with chylomicronemia from a novel mutation in GPIHBP1: a case report. Lin MH; Tian XH; Hao XL; Fei H; Yin JL; Yan DD; Li T BMC Pregnancy Childbirth; 2020 May; 20(1):272. PubMed ID: 32375710 [TBL] [Abstract][Full Text] [Related]
14. Causes, clinical findings and therapeutic options in chylomicronemia syndrome, a special form of hypertriglyceridemia. Paragh G; Németh Á; Harangi M; Banach M; Fülöp P Lipids Health Dis; 2022 Feb; 21(1):21. PubMed ID: 35144640 [TBL] [Abstract][Full Text] [Related]
15. Reduced psychological distress in familial chylomicronemia syndrome after patient support group intervention. Wilson LM; Cross RR; Duell PB J Clin Lipidol; 2018; 12(1):240-242. PubMed ID: 29195809 [TBL] [Abstract][Full Text] [Related]
17. Qualitative development of the PROMIS Profile v1.0-Familial Chylomicronemia Syndrome (FCS) 28. Kaiser K; Fox RS; Perschon C; Vera-Llonch M; Alonso J; Cubells L; Cella D Qual Life Res; 2023 Feb; 32(2):605-614. PubMed ID: 36310187 [TBL] [Abstract][Full Text] [Related]